US Market Report for Lancet and Lancing Devices 2017 - MedCore
The lancet and lancing device market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total lancet and lancing device market was the personal segment. Personal lancets and lancing devices are used by individuals who use personal meters to perform self-monitoring blood glucose (SMBG) on a daily basis. CMS competitive bidding had a significant impact on the personal lancet and lancing device market after substantial reimbursement cuts in July 2013 and July 2016, respectively. Lancet reuse is also a limiter of growth in the personal segment. The professional market comprises safety lancets, which are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Safety lancets are necessary to avoid the risk of needlestick injuries and the spread of blood-borne pathogens.
A lancet is a small needle with a plastic or rubber coating that fits into the top of a lancing device. Lancing devices are pen-like instruments which are used in conjunction with a lancet to draw blood to be applied to a glucose strip. Many lancets come as a component of blood glucose monitoring kits, and can be adjusted for injection depth. Reusable lancets are not as effective as they are more dull and painful and increase the risk of infection.